Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin

Trial Profile

Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin

Completed
Phase of Trial: Phase 0

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Daptomycin (Primary) ; Rifampicin
  • Indications Bacteraemia; Bacterial endocarditis; Osteomyelitis; Skin and soft tissue infections; Staphylococcal infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 03 Dec 2015 Planned End Date changed from 1 Oct 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 26 May 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top